David E. Shapiro

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 15 papers. Top paper: “Diagnostic Tests Distinguishing Good Tests From Bad and Even Ugly Ones”.

Diagnostic Tests Distinguishing Good Tests From Bad and Even Ugly Ones

Infection Control & Hospital Epidemiology(2000)10.1086/501760

N/A

3.6DataRank · unranked

36 citations

Barry M. Farr, David E. Shapiro, David Birnbaum

Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial

The Lancet HIV(2020)10.1016/s2352-3018(20)30038-2

N/A

1.7DataRank · unranked

46 citations

R. L. Morrison, David E. Shapiro, Nahida Chakhtoura, Maria Isabel S. Gouvea, Maria de Lourdes Benamor Teixeira +23 more

Maternal and infant renal safety following tenofovir disoproxil fumarate exposure during pregnancy in a randomized control trial

BMC Infectious Diseases(2022)10.1186/s12879-022-07608-8

N/A

0.378DataRank · unranked

5 citations

Bonus Makanani, Camlin Tierney, Mary Glenn Fowler, Dhayendre Moodley, Gerhard Theron +76 more

Self-reported Antiretroviral Adherence: Association With Maternal Viral Load Suppression in Postpartum Women Living With HIV-1 From Promoting Maternal and Infant Survival Everywhere, a Randomized Controlled Trial in Sub-Saharan Africa and India

JAIDS Journal of Acquired Immune Deficiency Syndromes(2022)10.1097/qai.0000000000003102

N/A

0.347DataRank · unranked

6 citations

Kevin Butler, David E. Shapiro, Patience Atuhaire, Taha E. Taha, Bonus Makanani +11 more

Pharmacokinetics and Safety of Remdesivir in Pregnant and Nonpregnant Women With COVID-19: Results From IMPAACT 2032

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae298

N/A

0.340DataRank · unranked

6 citations

Kristin Baltrusaitis, Diana F. Clarke, Sharon Nachman, Jennifer Jao, Murli Purswani +56 more

Pharmacokinetics and Safety of Single-Dose Tenofovir Disoproxil Fumarate and Emtricitabine in HIV-1-Infected Pregnant Women and Their Infants

UNC Libraries(2020)10.17615/dqr7-0g70

N/A

0DataRank · unranked

0 citations

Patrick Jean‐Philippe, Lynne Mofenson, James F. Rooney, Jack Rodman, Edwin Thorpe +13 more

Interactions between etonogestrel-releasing contraceptive implant and 3 antiretroviral regimens

Contraception(2021)10.1016/j.contraception.2021.08.006

N/A

0DataRank · unranked

5 citations

Alice Stek, Brookie M. Best, Edmund V. Capparelli, Jiajia Wang, David E. Shapiro +4 more

Fosamprenavir with Ritonavir Pharmacokinetics during Pregnancy

Antimicrobial Agents and Chemotherapy(2020)10.1128/aac.02260-19

N/A

0DataRank · unranked

11 citations

Jiajia Wang, Khadija Amin, David E. Shapiro, Alice Stek, Elizabeth Smith +42 more

Darunavir Pharmacokinetics With an Increased Dose During Pregnancy

JAIDS Journal of Acquired Immune Deficiency Syndromes(2020)10.1097/qai.0000000000002261

N/A

0DataRank · unranked

20 citations

Alice Stek, Jiajia Wang, Régis Kreitchmann, David E. Shapiro, Elizabeth Smith +6 more

Assessment of minority frequency pretreatment HIV drug-resistant variants in pregnant women and associations with virologic non-suppression at term

PLoS ONE(2022)10.1371/journal.pone.0275254

N/A

0DataRank · unranked

2 citations

Ingrid A. Beck, Sheila Styrchak, Samantha Hardy, Jackson Wallner, Ross Milne +6 more

Pharmacokinetics and safety of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum: results from IMPAACT P1026s

Antimicrobial Agents and Chemotherapy(2023)10.1128/aac.00737-23

N/A

0DataRank · unranked

16 citations

Adrie Bekker, Eric Decloedt, Jiajia Wang, Gerhard Theron, Mark F. Cotton +16 more

Participant acceptability and clinician satisfaction of cognitive behavioural therapy and medication management algorithm compared with enhanced standard care for treatment of depression among youth with HIV

Journal of Child and Adolescent Mental Health(2024)10.2989/17280583.2024.2387632

N/A

0DataRank · unranked

2 citations

Kristin Baltrusaitis, Betsy D. Kennard, Graham J. Emslie, Chelsea Krotje, Kevin Knowles +9 more

Cognitive Behavioral Therapy Factors Related to Outcomes in Depression Among Youth with HIV

Cognitive Therapy and Research(2024)10.1007/s10608-024-10474-0

N/A

0DataRank · unranked

0 citations

Larry K. Brown, Kristin Baltrusaitis, Miriam Chernoff, Graham J. Emslie, Jessica Jones +9 more

Enrollment and transition challenges in the International Maternal Pediatric and Adolescent AIDS Clinical Trials (IMPAACT) network’s PROMISE trial for resource-limited regions

Clinical Trials(2020)10.1177/1740774520912428

N/A

0DataRank · unranked

10 citations

Mary Glenn Fowler, Pat Flynn, Anne Coletti, Katie McCarthy, Renee Browning +6 more

Pharmacokinetics and Safety of Clofazimine in Women With Rifampicin-resistant Tuberculosis During Pregnancy and the Postpartum Period: Results From IMPAACT P1026s

The Journal of Infectious Diseases(2025)10.1093/infdis/jiaf504

N/A

0DataRank · unranked

3 citations

Flynn McMorrow, Kristina M. Brooks, Mauricio Pinilla, Lee Fairlie, James S. Ngocho +38 more